SS Pharmaceutical to Launch 'Cialis®', Japan's First Non-Prescription ED Treatment, on July 31st
NQ Score
97/100
N1 Content Completeness
5
AI Summary (NQ-processed)
SS Pharmaceutical will launch 'Cialis®', Japan's first switch-OTC ED medication, on July 31, 2026. Given findings that approximately one in two Japanese men may experience ED, the company aims to create an environment where treatment can be accessed with pharmacist guidance.
AI Analysis
Frequently Asked Questions
- Q: When will SS Pharmaceutical release Cialis® as a non-prescription ED treatment in Japan?
- A: SS Pharmaceutical will launch Cialis® as Japan's first switch-OTC ED medication on July 31, 2026.
- Q: What percentage of Japanese men may experience ED according to the findings mentioned in the article?
- A: Approximately one in two Japanese men may experience ED, as indicated in the article.
- Q: How does SS Pharmaceutical plan to facilitate access to Cialis® after its OTC launch?
- A: SS Pharmaceutical aims to create an environment where Cialis® can be accessed with pharmacist guidance.
- Q: What is the significance of the July 31, 2026 launch date for Cialis® in Japan?
- A: The July 31, 2026 launch marks the introduction of Japan's first non-prescription ED treatment, Cialis®.
- Q: Which pharmaceutical company is responsible for launching Cialis® as an OTC ED medication in Japan?
- A: SS Pharmaceutical is the company launching Cialis® as Japan's first switch-OTC ED medication in 2026.